Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
Clinical trial NCT05200143 · TERMINATED
Trial details
- NCT number
- NCT05200143
- Sponsor
- Providence Health & Services
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2023-09-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.